In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.…
Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
Cocaine use continues to increase in Western and Central Europe as well as South-Eastern Europe, according to several indicators of use and harm.In 2024, demand-side and supply-side domestic market indicators showed diverging trends in Western and Central Europe, suggesting localized disruptions…
In Australia, multiple drug-related indicators show an increase in cocaine use and associated harm between 2010 and 2021, particularly among men. However, cocaine still plays a relatively small role in overall drug-related harm, with only 2.7 per cent of people in drug-related treatment reporting…
In the United States and in Canada use of cocaine declined among young people until 2024, but not among the general population. Men continue to account for higher levels of use and harms than women, with cocaine-related overdose deaths rising much more sharply for men over the past decade –…
Cocaine is the second most used drug in Europe, after cannabis. However, per capita consumption of the substance tends to be lower than in the Americas.Annual use of cocaine is relatively high in Western and Central Europe (the subregion with the third highest average prevalence in the world) and…
Over the past decade, the prevalence of cocaine use has remained relatively stable in some countries of South America while increasing in others. However, the most recent data from countries where available show signs of stabilization.A wide variety of cocaine products are used in the region,…
The use of amphetamines has distinct regional patterns; past-year use is generally higher among men (0.85 per cent) than women (0.34 per cent) globally.The largest markets for ATS, mainly methamphetamine, remain East and South-East Asia and North America. The highest past-year use of amphetamines…
“Ecstasy” use remains highest in high income countries and parts of Asia.Past-year use of "ecstasy" globally is estimated at 0.4 per cent among those aged 15-64. Use is higher among men (0.54 per cent) than women (0.26 per cent), but the difference is not as pronounced as for other drugs (for…
Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching…
“Ecstasy” use remains concentrated in Europe (mainly Western and Central Europe)Use is significantly higher in Western and Central Europe than in Eastern and South-Eastern Europe, both in terms of prevalence (1.2 per cent vs. 0.4 per cent) and number of users (nearly 4 million versus less than 800,…
Cocaine use and related harms have increased globally over the past two decades, despite recent disruptions.Approximately 25 million people worldwide are estimated to have used cocaine in 2024 (or 0.47 per cent of the population aged 15-64), with lower estimated use among women (0.24 per cent) than…
